A prediction method for the individual serum concentration and therapeutic effect for optimizing adalimumab therapy in inflammatory bowel disease.
第一作者:
Koji,Kimura
第一单位:
Department of Clinical Evaluation of Drug Efficacy, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan.
作者:
主题词
人类(Humans);贝叶斯定理(Bayes Theorem);炎性肠疾病(Inflammatory Bowel Diseases);成年人(Adult);女(雌)性(Female);男(雄)性(Male);中年人(Middle Aged);消炎药(Anti-Inflammatory Agents);治疗结果(Treatment Outcome);青年人(Young Adult);模型, 生物学(Models, Biological);缓解诱导(Remission Induction)
DOI
10.1093/jpp/rgae092
PMID
39010700
发布时间
2025-04-22
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



